Manufacturer
Nomax, Inc.
3 drugs, 7 product strengths, 8 recalls on record.
Drugs Nomax, Inc. makes
Recalls
Class IIOngoingMay 1, 2024GloStripsFailed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in...Nomax Inc · D-0462-2024Class IIOngoingMay 1, 2024GloStripsFailed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in...Nomax Inc · D-0463-2024Class IIOngoingMay 1, 2024FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USPFailed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in...Nomax Inc · D-0464-2024Class IIOngoingMay 1, 2024FUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mgFailed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in...Nomax Inc · D-0465-2024Class IIITerminatedMay 26, 2021Dry Eye TestSubpotent DrugNomax Inc · D-0387-2021Class IIITerminatedApr 29, 2015Fluorescein Sodium Ophthalmic Strips USPFailed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging...Nomax Inc · D-0961-2015Class IIITerminatedApr 29, 2015Rose Bengal GloStripsFailed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging...Nomax Inc · D-0962-2015Class IIITerminatedApr 29, 2015Fluorescein Sodium Ophthalmic Strips USPFailed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging...Nomax Inc · D-0963-2015
About Nomax, Inc.
No comments yet. Questions, tips, what worked for you - start the conversation.